Trexquant Investment’s Bicycle Therapeutics BCYC Stock Holding History

Trexquant Investment’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Buy	+31,044	New	+$142K	﹤0.01%	1820
2024 Q2	–	Sell	-92,552	Closed	-$2.3M	–	1521
2024 Q1	$2.3M	Sell	92,552 -103,771	-53%	-$2.2M	0.05%	592
2023 Q4	$3.55M	Buy	196,323 +125,604	+178%	+$2.08M	0.08%	358
2023 Q3	$1.42M	Buy	+70,719	New	+$1.62M	0.04%	611
2022 Q3	–	Sell	-10,899	Closed	-$183K	–	1363
2022 Q2	$183K	Buy	+10,899	New	+$230K	0.01%	1373
2022 Q1	–	Sell	-4,370	Closed	-$266K	–	1359
2021 Q4	$266K	Buy	+4,370	New	+$241K	0.02%	992

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc London $602M AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Trexquant Investment's BCYC Position: Q2 2026 in Review

Trexquant Investment opened a new position in Bicycle Therapeutics (BCYC) in Q2 2026: 31,044 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #1820 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in BCYC as recently as Q1 2024.

Trexquant Investment first reported a position in BCYC in Q4 2021 and has held it in 6 quarters since. The position peaked at $3.55M in Q4 2023. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

Trexquant Investment held 31,044 shares of Bicycle Therapeutics worth $132K as of Q2 2026.
Bicycle Therapeutics was a new Trexquant Investment position in Q2 2026.
Bicycle Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1820 holding.
Trexquant Investment first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 6 quarters since.
Trexquant Investment's Bicycle Therapeutics position peaked at $3.55M in Q4 2023.
103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.